You are here » Home » Companies » Company Overview » Anuh Pharma Ltd

Anuh Pharma Ltd.

BSE: 506260 Sector: Health care
NSE: N.A. ISIN Code: INE489G01022
BSE 00:00 | 20 May 99.10 2.15
(2.22%)
OPEN

98.80

HIGH

100.00

LOW

97.00

NSE 05:30 | 01 Jan Anuh Pharma Ltd
OPEN 98.80
PREVIOUS CLOSE 96.95
VOLUME 13646
52-Week high 156.00
52-Week low 84.60
P/E 16.25
Mkt Cap.(Rs cr) 497
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 98.80
CLOSE 96.95
VOLUME 13646
52-Week high 156.00
52-Week low 84.60
P/E 16.25
Mkt Cap.(Rs cr) 497
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Anuh Pharma Ltd. (ANUHPHARMA) - Chairman Speech

Company chairman speech

Dear Shareholders

Our Company has been bestowed with the responsibility of providingquality bulk drugs to formulation companies. We have a strong client base of 350Indian/Multinational companies. During the financial year 2020-2021 the main challengewas to run the Company despite several factors related to the pandemic lockdowns. Theseinclude:

i) Picking and dropping employees

ii) Social distancing

iii) Sanitization

iv) Ensuring pandemic related safety measures like wearing masks etc.

We have successfully performed throughout the year and provided timelyservice to all our esteemed clients.

As we reel under the effects of the second wave we still continue toface similar challenges. With tremendous support from staff and workers we are confidentthat we will keep the wheels of production rolling.

It is my great pleasure to present to you our Company's 61stAnnual Report in a nutshell.

Our operational revenue for the financial year 2020-2021 amounted to '43196 lakhs as against ' 30696 lakhs for the previous year an increase of 40.70%

Our profit before tax as compared to last year has increased by 101.25%from ' 1916 lakhs to ' 3855 lakhs and profit after tax has increased by 99% from ' 1431lakhs to ' 2844 lakhs.

We could achieve above good results in spite of huge depreciation of '1508 lakhs for the financial year 2020-2021.

EXPANSION PROJECT:

Our "New Expansion project" is fully operational and due tothis increased capacity we hope to continuously achieve higher topline and bottom-line.

We continue to allocate total resources towards building the API andBulk Drugs segment. Our R&D facility at Navi Mumbai works relentlessly on thedevelopment of newer and better pharmaceutical raw materials.

TRANSFORMATION:

In order to generate long term sustainable value for shareholdersbusinesses need to continuously involve and transform themselves to build a strongfoundation for future growth.

At Anuh Pharma we have decided on a transformational journey to ensurethat the Company is aligned in tune with the times.

.